Child: Clinical Trials

3 trials for Child, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3
Phase 31Unknown 1

Follow Child: new trials by email Literature Review of Child trials Research Report on Child

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of NF1-related Plexiform Neurofibroma With Trametinib
Trametinib - Neurofibromatosis 1, Child
Phase 2UnknownRegion Skane152019-06-102024-04-11
Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT
lipoprostaglandin E1 - Veno-occlusive Disease, Child
Phase 2 / Phase 3UnknownSeoul National University Hospital302015-01-012021-03-30
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children
high dose methotrexate, Intrathecal triple chemotherapy - Acute Lymphoblastic Leukemia, Child
Phase 2UnknownThe Korean Society of Pediatric Hematology Oncology1102015-01-012015-01-16

Narrower conditions

Neurofibroma, Plexiform (1)  ·  Neurofibromatosis 1 (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplastic Syndromes, Hereditary (1)

Interventions

Methotrexate (1)  ·  trametinib (1)

Sponsors

Region Skane (1)  ·  Seoul National University Hospital (1)  ·  The Korean Society of Pediatric Hematology Oncology (1)

Countries

South Korea (2)  ·  Sweden (1)

Top investigators

Hyoung Jin Kang, MD, PhD (1)

NIH funding

2018 (1)